Market Research Report

Product code

937208

Preimplantation Genetic Testing Market, By PGD/PGS, By Type, By Application and By Geography - Analysis, Share, Trends, Size, & Forecast From 2020 - 2026

Published: May 1, 2020 |

AnalystView Market Insights | 233 Pages | Delivery time: 2-3 business days

Price

Description
Table of Contents
List of Tables

Add to Compare

REPORT HIGHLIGHT

Preimplantation genetic testing market was valued at USD 175.3 million by 2019, growing with 9.2% CAGR during the forecast period, 2020-2026

Market Dynamics

Abnormality in the chromosomal number is the prime cause of failure in the pregnancy concieved in natural or by invitro fertilization. Espeically in case of IVF, different technologies have introduced to identify that equal number of chromosomes are present in each of the haploid chromosomal set. Preimplantation genetic testing (PGT) also known as embryo biopsy is the test performed on the embryo for analzing the genetic abnormalities prior to its incorporation into the womb in the process of in-vitro fertilization (IVF). It is used for identification of any possible genetic defect in these embryos in IVF. It is early type of prenatal genetic diagnosis used for investigating prenatal screening of the emobryo prior to implantation. PGT is performed for ensuring that the embryo introduced shows high prevalence of healthy and normal pregnancy. PGT has emegered as an useful test for the couples with genetic disorders, which have high probablity of transferring into the baby as well.

PGT involves testing of monogentic diseases, structural aggrangement of the chromosome and abnormal chromosomal number. The growth of the PGT market is experiencing growth owing to rise in success rate in the in-vitro fertilzation. Increasing adoption of IVF technique due to rising issues regarding infertility within both genders, an outcome of unhealthy lifestyle. Ongoing advancement in the area of IVF, to increase chance of healthy pregnancy, is driving the worldwide industry growth. Also, rise in genetic disorders is another factor fueling the demand for IVF. According to the World Health Organization (WHO), the prevalence of all single-gene disorders at birth is 10 in 1,000. Aforementioned factors would, in turn, support the market growth to great extent. On the flip side, high cost associated with this procedure is expected to pull back the market growth in future. In addition to this, ethical concerns with PGT is another factor hindering the market growth.

PGD/PGS Takeaway

Among PGD and PGS, PGD accounted for more than 50% of the total market share in 2019. Preimplantation genetic diagnosis (PGD) includes testing of the embryo having either of the parents with some kind of genetic abnormilities. Rise in genetic disorders with higher awareness regarding inheritance of the genetic disorders is driving the demnad for PGD testing. Also, higher efficiency of PGD to detect the genetic disorders in the embryo is also promoting its adoption. Also, different studies has revealed that PGD possess ability to diagose over 2,000 inherited single gene disorders with accuracy of around 98% in identifying affected and unaffected embryos.

Type Takeaway

Basis on types, the market is divided into chromosomal abnormalities, HLA Typing, embryo testing, X-linked diseases, and aneuploidy screening. In 2019, the chromosomal abnormalities gained highest market share. Increasing use of PGT for eliminating the risk associated with miscarriage and improve success of IVF. High incidence of chromosomal incidence in the IVF embryos lowering the success chances of the IVF. Various studies revealed that over 50% of the preimplantation embryos have abnormal chromosomal number including polyploidy or aneuploid. This, drives the demand for preimplantation genetic testing market.

Application Takeaway

Application segment is further classified into the IVF prognosis, embryo HLA typing, late onset genetic disorders, and inherited genetic disease. Out of these, in 2019, the embryo HLA typing category gained the leading position valued at USD 55.9 million. It is important in preventing tranferring of the genetic diseases. The adoption of the PGT with HLA typing is increasing at a significant pace owing to increase in awareness among the couples as a radical treatment. HLA typing has emerged as new method of treatment with higher preference especially fot the diseases requiring stem cell transplantation for potential treatment.

Regional Takeaway

On the basis of region, the North America and Europe accounted for significant poisition in the preimplantation genetic testing market. In North America, the rise in infertility issues especially among the couples suffering from genetic disorders is driving the demand for PGT, for sucessful pregnancy. As per American Society for Reproductive Medicine, 15% of the couples are infected the fertility wherein around 15%-30% of male factor infertility is owing to genetic abnormalities. Increasing patient pool with higher adoption of the PGT in the Europe is boosting the regional market growth.

Key Vendor Takeaway

F. Hoffmann-La Roche Ltd., Genea Limited, Illumina, Inc., Quest Diagnostics Incorporated., Natera Inc., CooperSurgical, Inc., Laboratory Corporation of America Holdings, Thermo Fisher Scientific, Inc., Igenomix, Bioarray S.L., Oxford Gene Technology, Invitae Corporation, PerkinElmer Inc., Reproductive Genetic Innovations, LLC. and California Pacific Medical Center (CPMC) are the key players operating in the preimplantation genetic testing market.

Increasing clinical studies directing towards second-generation preimplantation with unfavorable reproductive and IVF prognosis for improved outcome. Companies are entering into partnership and new product launches for preimplantation genetic testing. For instance, in 2019, Illumina partnered with the Vitrolife for distribution of pre-implantation genetic testing kit. This kit was specifically designed for monogenic and single gene defects (HumanKaryomap-12) and aneuploidy (PGT-A) (VeriSeq PGS). Likewise, in October 2019, PerkinElmer launched PG-Seq Rapid Non-Invasive Preimplantation Genetic Testing for Aneuploidy (PGT-A) kit.

The market size and forecast for each segment and sub-segments has been considered as below:

Historical Year - 2015 to 2018

Base Year - 2019

Estimated Year - 2020

Projected Year - 2026

TARGET AUDIENCE

Traders, Distributors, and Suppliers

Manufacturers

Government and Regional Agencies

Research Organizations

Consultants

Distributors

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET KEY PLAYERS

Thermo Fisher Scientific, Inc.

Igenomix

Bioarray S.L.

Quest Diagnostics Incorporated.

Natera Inc.

Oxford Gene Technology

Invitae Corporation

PerkinElmer Inc.

Reproductive Genetic Innovations, LLC

California Pacific Medical Center (CPMC)

F. Hoffmann-La Roche Ltd.

Genea Limited

Illumina, Inc.

CooperSurgical, Inc.

Laboratory Corporation of America Holdings

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET BY PGD/PGS

Preimplantation Genetic Screening (PGS)

Preimplantation Genetic Diagnosis (PGD)

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY TYPE

Aneuploidy Screening

Chromosomal Abnormalities

HLA Typing

X-linked Diseases

Embryo Testing

Fresh Embryo (Donor Eggs)

Fresh Embryo (Own Eggs)

Frozen Embryo (Donor Eggs)

Frozen Embryo (Own Eggs)

Other PGT Types

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY APPLICATION

Late Onset Genetic Disorders

Inherited Genetic Disease

Embryo HLA typing for stem cell therapy

IVF Prognosis

Others

GLOBAL PREIMPLANTATION GENETIC TESTING MARKET, BY REGION

North America

The U.S.

Canada

Europe

Germany

France

Italy

Spain

United Kingdom

Rest of Europe

Asia Pacific

India

China

South Korea

Japan

Singapore

Rest of APAC

Latin America

Brazil

Mexico

Argentina

Rest of LATAM

Middle East and Africa

Saudi Arabia

United Arab Emirates

Rest of MEA

TABLE OF CONTENT

1. PREIMPLANTATION GENETIC TESTING MARKET OVERVIEW

1.1. Study Scope
1.2. Assumption and Methodology

2. EXECUTIVE SUMMARY

2.1. Market Snippet

2.1.1. Market Snippet by PGD/PGS
2.1.2. Market Snippet by Type
2.1.3. Market Snippet by Application
2.1.4. Market Snippet by Region

2.2. Competitive Insights

3. PREIMPLANTATION GENETIC TESTING KEY MARKET TRENDS

3.1. Market Drivers

3.1.1. Impact Analysis of Market Drivers

3.2. Market Restraints

3.2.1. Impact Analysis of Market Restraints

3.3. Market Opportunities
3.4. Market Future Trends

4. PREIMPLANTATION GENETIC TESTING INDUSTRY STUDY

4.1. Porter's Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. PREIMPLANTATION GENETIC TESTING MARKET LANDSCAPE

5.1. Market Share Analysis
5.2. Key Innovators
5.3. Breakdown Data, by Key manufacturer

5.3.1. Established Player Analysis
5.3.2. Emerging Player Analysis

6. PREIMPLANTATION GENETIC TESTING MARKET - BY PGD/PGS

6.1. Overview

6.1.1. Segment Share Analysis, By Type, 2019 & 2026 (%)

6.2. Preimplantation Genetic Diagnosis (PGD)

6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

6.3. Preimplantation Genetic Screening (PGS)

6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7. PREIMPLANTATION GENETIC TESTING MARKET - BY TYPE

7.1. Overview

7.1.1. Segment Share Analysis, By Type, 2019 & 2026 (%)

7.2. Chromosomal Abnormalities

7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7.3. X-linked Diseases

7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7.4. Embryo Testing

7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)
7.4.3. Fresh Embryo (Own Eggs)

7.4.3.1. Overview
7.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7.4.4. Frozen Embryo (Own Eggs)

7.4.4.1. Overview
7.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7.4.5. Fresh Embryo (Donor Eggs)

7.4.5.1. Overview
7.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7.4.6. Frozen Embryo (Donor Eggs)

7.4.6.1. Overview
7.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7.5. Aneuploidy Screening

7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7.6. HLA Typing

7.6.1. Overview
7.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

7.7. Other PGT Types

7.7.1. Overview
7.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8. PREIMPLANTATION GENETIC TESTING MARKET - BY APPLICATION

8.1. Overview

8.1.1. Segment Share Analysis, By Application, 2019 & 2026 (%)

8.2. Embryo HLA typing for stem cell therapy

8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8.3. IVF Prognosis

8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8.4. Late Onset Genetic Disorders

8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8.5. Inherited Genetic Disease

8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

8.6. Others

8.6.1. Overview
8.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9. PREIMPLANTATION GENETIC TESTING MARKET- BY GEOGRAPHY

9.1. Introduction

9.1.1. Segment Share Analysis, By Region, 2019 & 2026 (%)

9.2. North America

9.2.1. Overview
9.2.2. Key Manufacturers in North America
9.2.3. North America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.2.4. North America Market Size and Forecast, By PGD/PGS, 2015 - 2026 (US$ Million)
9.2.5. North America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
9.2.6. North America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
9.2.7. U.S.

9.2.7.1. Overview
9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.2.8. Canada

9.2.8.1. Overview
9.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.3. Europe

9.3.1. Overview
9.3.2. Key Manufacturers in Europe
9.3.3. Europe Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.3.4. Europe Market Size and Forecast, By PGD/PGS, 2015 - 2026 (US$ Million)
9.3.5. Europe Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
9.3.6. Europe Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
9.3.7. Germany

9.3.7.1. Overview
9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.3.8. Italy

9.3.8.1. Overview
9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.3.9. United Kingdom

9.3.9.1. Overview
9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.3.10. France

9.3.10.1. Overview
9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.3.11. Rest of Europe

9.3.11.1. Overview
9.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.4. Asia Pacific (APAC)

9.4.1. Overview
9.4.2. Key Manufacturers in Asia Pacific
9.4.3. Asia Pacific Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.4.4. Asia Pacific Market Size and Forecast, By PGD/PGS, 2015 - 2026 (US$ Million)
9.4.5. Asia Pacific Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
9.4.6. Asia Pacific Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
9.4.7. India

9.4.7.1. Overview
9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.4.8. China

9.4.8.1. Overview
9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.4.9. Japan

9.4.9.1. Overview
9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.4.10. South Korea

9.4.10.1. Overview
9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.4.11. Rest of APAC

9.4.11.1. Overview
9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.5. Latin America

9.5.1. Overview
9.5.2. Key Manufacturers in Latin America
9.5.3. Latin America Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.5.4. Latin America Market Size and Forecast, By PGD/PGS, 2015 - 2026 (US$ Million)
9.5.5. Latin America Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
9.5.6. Latin America Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
9.5.7. Brazil

9.5.7.1. Overview
9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.5.8. Mexico

9.5.8.1. Overview
9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.5.9. Argentina

9.5.9.1. Overview
9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.5.10. Rest of LATAM

9.5.10.1. Overview
9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.6. Middle East and Africa

9.6.1. Overview
9.6.2. Key Manufacturers in Middle East and Africa
9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2015 - 2026 (US$ Million)
9.6.4. Middle East and Africa Market Size and Forecast, By PGD/PGS, 2015 - 2026 (US$ Million)
9.6.5. Middle East and Africa Market Size and Forecast, By Type, 2015 - 2026 (US$ Million)
9.6.6. Middle East and Africa Market Size and Forecast, By Application, 2015 - 2026 (US$ Million)
9.6.7. Saudi Arabia

9.6.7.1. Overview
9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

9.6.8. United Arab Emirates

9.6.8.1. Overview
9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2015 - 2026, (US$ Million)

10. KEY VENDOR ANALYSIS

10.1. F. Hoffmann-La Roche Ltd.

10.1.1. Company Snapshot
10.1.2. Financial Performance
10.1.3. Product Benchmarking
10.1.4. Strategic Initiatives

10.2. CooperSurgical, Inc.
10.3. Laboratory Corporation of America Holdings
10.4. Thermo Fisher Scientific, Inc.
10.5. Igenomix
10.6. Bioarray S.L.
10.7. Oxford Gene Technology
10.8. Invitae Corporation
10.9. PerkinElmer Inc.
10.10. Genea Limited, Illumina, Inc.
10.11. Quest Diagnostics Incorporated.
10.12. Natera Inc.
10.13. Reproductive Genetic Innovations, LLC.
10.14. California Pacific Medical Center (CPMC)

11. 360 DEGREE ANALYSTVIEW

12. APPENDIX

12.1. Research Methodology
12.2. References
12.3. Abbreviations
12.4. Disclaimer
12.5. Contact Us

List of Tables

TABLE List of data sources
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Preimplantation genetic testing market: PGD/PGS Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by PGD/PGS
TABLE Global Preimplantation genetic testing market, by PGD/PGS 2015-2026 (USD Million)
TABLE Preimplantation genetic testing market: Type Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Type
TABLE Global Preimplantation genetic testing market, by Type 2015-2026 (USD Million)
TABLE Preimplantation genetic testing market: Application Snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Application
TABLE Global Preimplantation genetic testing market, by Application 2015-2026 (USD Million)
TABLE Preimplantation genetic testing market: Regional snapshot (2018)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Preimplantation genetic testing market, by Region 2015-2026 (USD Million)
TABLE North America Preimplantation genetic testing market, by Country, 2015-2026 (USD Million)
TABLE North America Preimplantation genetic testing market, by PGD/PGS, 2015-2026 (USD Million)
TABLE North America Preimplantation genetic testing market, by Type, 2015-2026 (USD Million)
TABLE North America Preimplantation genetic testing market, by Application, 2015-2026 (USD Million)
TABLE Europe Preimplantation genetic testing market, by country, 2015-2026 (USD Million)
TABLE Europe Preimplantation genetic testing market, by PGD/PGS, 2015-2026 (USD Million)
TABLE Europe Preimplantation genetic testing market, by Type, 2015-2026 (USD Million)
TABLE Europe Preimplantation genetic testing market, by Application, 2015-2026 (USD Million)
TABLE Asia Pacific Preimplantation genetic testing market, by country, 2015-2026 (USD Million)
TABLE Asia Pacific Preimplantation genetic testing market, by PGD/PGS, 2015-2026 (USD Million)
TABLE Asia Pacific Preimplantation genetic testing market, by Type, 2015-2026 (USD Million)
TABLE Asia Pacific Preimplantation genetic testing market, by Application, 2015-2026 (USD Million)
TABLE Latin America Preimplantation genetic testing market, by country, 2015-2026 (USD Million)
TABLE Latin America Preimplantation genetic testing market, by PGD/PGS, 2015-2026 (USD Million)
TABLE Latin America Preimplantation genetic testing market, by Type, 2015-2026 (USD Million)
TABLE Latin America Preimplantation genetic testing market, by Application, 2015-2026 (USD Million)
TABLE Middle East and Africa Preimplantation genetic testing market, by country, 2015-2026 (USD Million)
TABLE Middle East and Africa Preimplantation genetic testing market, by PGD/PGS, 2015-2026 (USD Million)

TABLE Middle East and Africa Preimplantation genetic testing market, by Type, 2015-2026 (USD Million)

TABLE Middle East and Africa Preimplantation genetic testing market, by Application, 2015-2026 (USD Million)